2014
June 18, 2014
Genelex, a pioneer in pharmacogenetic testing, analysis and comprehensive medication management software that helps medical professionals understand the interaction between a patient’s genetics and More..
Genelex, a pioneer in pharmacogenetic testing, analysis and comprehensive medication management software that helps medical professionals understand the interaction between a patient’s genetics and More..
June 4, 2014
New Research Reveals Significant Impact of Drug-Gene and Drug-Drug-Gene Interactions Seattle (June 5, 2014) – Why do some patients react differently to the same drug? A new More..
New Research Reveals Significant Impact of Drug-Gene and Drug-Drug-Gene Interactions Seattle (June 5, 2014) – Why do some patients react differently to the same drug? A new More..
2013
December 17, 2013
New team of patient care, medical technology, reimbursement and pharmacology experts to help inform development and clinical utility of YouScript® Personalized Prescribing System. SEATTLE, WA—December 17, 2013— More..
New team of patient care, medical technology, reimbursement and pharmacology experts to help inform development and clinical utility of YouScript® Personalized Prescribing System. SEATTLE, WA—December 17, 2013— More..
2012
September 12, 2012
DNA test system, covered by insurance, could save countless lives and hundreds of millions in US health care costs (SEATTLE) – A new medical test system More..
DNA test system, covered by insurance, could save countless lives and hundreds of millions in US health care costs (SEATTLE) – A new medical test system More..
August 13, 2012
Seattle, WA—Genelex Corporation today announced the acceptance of US Patent 8,099,298 titled, “Genetic Data Analysis and Database Tools.” Genelex’s patent, filed in early 2007, covers More..
Seattle, WA—Genelex Corporation today announced the acceptance of US Patent 8,099,298 titled, “Genetic Data Analysis and Database Tools.” Genelex’s patent, filed in early 2007, covers More..
June 22, 2012
Seattle, Washington - Genelex Corporation is pleased to announce the appointment of Rajeev Pany as Director of Software Development. Rajeev comes to Genelex with 15 More..
Seattle, Washington - Genelex Corporation is pleased to announce the appointment of Rajeev Pany as Director of Software Development. Rajeev comes to Genelex with 15 More..
2010
July 14, 2010
Advanced tools for preventing Plavix and other treatment failures and adverse side effects now more widely available to doctors July 13, 2010 – SEATTLE, Washington and TULSA, More..
Advanced tools for preventing Plavix and other treatment failures and adverse side effects now more widely available to doctors July 13, 2010 – SEATTLE, Washington and TULSA, More..
July 9, 2010
“Advanced tools for preventing treatment failure and adverse side effects to be available to Greek doctors, pharmacists and patients.” (SEATTLE, USA and ATHENS, GREECE) – The More..
“Advanced tools for preventing treatment failure and adverse side effects to be available to Greek doctors, pharmacists and patients.” (SEATTLE, USA and ATHENS, GREECE) – The More..
June 8, 2010
Merger signals significant advance in personalized medicine (SEATTLE, Wash. and LEXINGTON, Mass.) — The first-ever comprehensive personalized prescribing services company has been formed with the merger More..
Merger signals significant advance in personalized medicine (SEATTLE, Wash. and LEXINGTON, Mass.) — The first-ever comprehensive personalized prescribing services company has been formed with the merger More..
2009
October 21, 2009
(SEATTLE) – Five hundred thousand women in the U.S. are taking tamoxifen to prevent breast cancer recurrence. Almost half of them have a gene variation More..
1
2
3
Next » (SEATTLE) – Five hundred thousand women in the U.S. are taking tamoxifen to prevent breast cancer recurrence. Almost half of them have a gene variation More..
